1-4 of 4
Rebecca Slack
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cladribine Combined with Idarubicin and High-Dose AraC (CLIA2) As a Frontline and Salvage Treatment for Young Patients (≤65 yrs) with Acute Myeloid Leukemia

Mansour Alfayez, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Marina Y. Konopleva, MD PhD, Naval G. Daver, MD, Courtney D. DiNardo, MD MSc, Gautam Borthakur, MD, Prithviraj Bose, MD, Michael Andreeff, MD PhD, Yesid Alvarado, MD, Musa E. Yilmaz, MD, Naveen Pemmaraju, MD, Steven M. Kornblau, MD, Zeev E. Estrov, MD, Christopher B. Benton, MD, Koichi Takahashi, MD, Kiran Naqvi, MD MPH, Rebecca Slack, MS, Rubiul Islam, MD, Elias J. Jabbour, MD, Jorge E. Cortes, MD, Tapan M. Kadia, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4039.
https://doi.org/10.1182/blood-2018-99-119271
Published: 2018
Journal Articles

Outcomes By Treatment Setting and Genomic Profile in Patients with AML on Cladribine, Idarubicin, and Cytarabine

Prajwal Boddu, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MBBS, Elias J. Jabbour, MD, Naval Daver, MD, Naveen Pemmaraju, MD, Courtney D. DiNardo, MDMSc, Srdan Verstovsek, MD PhD, Yesid Alvarado, MD, Gautam Borthakur, MD, Nitin Jain, MD, Marina Konopleva, MD PhD, Christopher B Benton, MD, Rebecca Slack, MS, Keyur P. Patel, MBBS, PhD, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Tapan Kadia, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3898.
https://doi.org/10.1182/blood.V130.Suppl_1.3898.3898
Published: 2017
Journal Articles

Optimal Timing of Allogeneic Stem Cell Transplantation (Allo-SCT) for Chronic Myeloid Leukemia (CML) Patients in the Tyrosine Kinase Inhibitor (TKI) Era

Bei Hu, Xiao Lin, ^, Hans C. Lee, MD, Xuelin Huang, PhD, Rebecca Slack, MS, Elias J. Jabbour, MD, Srdan Verstovsek, MD PhD, Farhad Ravandi, MBBS, Guillermo Garcia-Manero, MD, Richard E Champlin, MD, Zhen-Huan Hu, MPH, Kwang Woo Ahn, PhD, Ying Lee, MD, Uday Popat, MD, Ronald Sobecks, MD, Edwin Alyea, MD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD, Wael Saber, MD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 4582.
https://doi.org/10.1182/blood.V130.Suppl_1.4582.4582
Published: 2017
Journal Articles

A Prognostic Model Using ZAP- 70, CD38 and Cytogenetics To Better Predict Need for Early Therapy and Response to Treatment in Chronic Lymphocytic Leukemia (CLL).

Peter Acs, MD, Blanche Mavromatis, MD, Metin Ozdemirly, MD, Daniel Hartmann, PhD, Jean Meck, PhD, Emre Zafer, MD, Rebecca Slack, Bruce Cheson, MD
Journal: Blood
Blood (2005) 106 (11): 2114.
https://doi.org/10.1182/blood.V106.11.2114.2114
Published: 2005